330 related articles for article (PubMed ID: 30671807)
1. Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection.
Mak LY; Wong DK; Seto WK; Ning Q; Cheung KS; Fung J; Lai CL; Yuen MF
Hepatol Int; 2019 Mar; 13(2):148-156. PubMed ID: 30671807
[TBL] [Abstract][Full Text] [Related]
2. Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection.
Mak LY; Wong DK; Cheung KS; Seto WK; Lai CL; Yuen MF
Clin Transl Gastroenterol; 2018 Jun; 9(6):163. PubMed ID: 29915243
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.
Xu H; Kong W; Liu L; Chi X; Wang X; Wu R; Gao X; Wang H; Qu L; Qi Y; Pan Y; Niu J
BMC Gastroenterol; 2017 May; 17(1):62. PubMed ID: 28486931
[TBL] [Abstract][Full Text] [Related]
4. Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection.
Mak LY; Wong DK; Cheung KS; Hui RW; Liu F; Fung J; Seto WK; Yuen MF
Dig Dis Sci; 2022 Nov; 67(11):5127-5136. PubMed ID: 35258755
[TBL] [Abstract][Full Text] [Related]
5. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals.
Saleh SA; Salama MM; Alhusseini MM; Mohamed GA
World J Gastroenterol; 2020 Jun; 26(21):2864-2876. PubMed ID: 32550761
[TBL] [Abstract][Full Text] [Related]
6. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients.
Mak LY; To WP; Wong DK; Fung J; Liu F; Seto WK; Lai CL; Yuen MF
World J Gastroenterol; 2019 Mar; 25(11):1398-1408. PubMed ID: 30918432
[TBL] [Abstract][Full Text] [Related]
7. Serum Mac-2 binding protein glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation.
Yamada N; Katano T; Hirata Y; Okada N; Sanada Y; Ihara Y; Urahashi T; Ushijima K; Karasawa T; Takahashi M; Mizuta K
J Gastroenterol Hepatol; 2019 Feb; 34(2):418-424. PubMed ID: 30101431
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients.
Sulaiman AS; Hasan I; Lesmana CRA; Kurniawan J; Jasirwan COM; Nababan S; Kalista KF; Hanifa RS; Rachmani D; Gani RA
Acta Med Indones; 2022 Oct; 54(4):567-573. PubMed ID: 36624717
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of Mac-2 binding protein glycosylation isomer (M2BPGi) in screening liver fibrosis in health checkups.
Nah EH; Cho S; Kim S; Kim HS; Cho HI
J Clin Lab Anal; 2020 Aug; 34(8):e23316. PubMed ID: 32227396
[TBL] [Abstract][Full Text] [Related]
10. Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B.
Noguchi R; Kaji K; Namisaki T; Moriya K; Kitade M; Takeda K; Kawaratani H; Okura Y; Aihara Y; Furukawa M; Mitoro A; Yoshiji H
World J Gastroenterol; 2017 Sep; 23(36):6705-6714. PubMed ID: 29085215
[TBL] [Abstract][Full Text] [Related]
11. Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.
Mak LY; Ko M; To E; Wong DK; Ma JH; Hui TL; Seto WK; Fung J; Lai CL; Yuen MF
J Gastroenterol Hepatol; 2019 Oct; 34(10):1817-1823. PubMed ID: 30786068
[TBL] [Abstract][Full Text] [Related]
12. Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis.
Su TH; Peng CY; Tseng TC; Yang HC; Liu CJ; Liu CH; Chen PJ; Chen DS; Kao JH
J Infect Dis; 2020 Feb; 221(4):589-597. PubMed ID: 31574141
[TBL] [Abstract][Full Text] [Related]
13. Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia.
Yamada N; Sanada Y; Tashiro M; Hirata Y; Okada N; Ihara Y; Urahashi T; Mizuta K
J Gastroenterol; 2017 Feb; 52(2):245-252. PubMed ID: 27349650
[TBL] [Abstract][Full Text] [Related]
14. On-treatment Serum Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) Level and Risk of Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B during Nucleot(s)ide Analogue Therapy.
Murata A; Amano N; Sato S; Tsuzura H; Tomishima K; Sato S; Matsumoto K; Shimada Y; Iijima K; Genda T
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192084
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases.
Moon HW; Park M; Hur M; Kim H; Choe WH; Yun YM
Ann Lab Med; 2018 Jul; 38(4):331-337. PubMed ID: 29611383
[TBL] [Abstract][Full Text] [Related]
16. Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B.
Bui HH; Nguyen ST; Phan ST; Nguyen KM; Nguyen CD
Dig Dis Sci; 2023 Dec; 68(12):4407-4417. PubMed ID: 37861877
[TBL] [Abstract][Full Text] [Related]
17. On-treatment changes of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein are associated with the regression of liver fibrosis in chronic hepatitis B patients on interferon α add-on therapy.
Liu T; Sun Y; Zhou J; Yang F; Zou X; Wang L; Wu X; Chen Y; Piao H; Lu L; Jiang W; Xu Y; Feng B; Nan Y; Xie W; Chen G; Zheng H; Li H; Ding H; Liu H; Wang T; Ou X; Wu S; Kong Y; Wang P; Cong M; Zhang Y; You H; Jia J
J Med Virol; 2019 Aug; 91(8):1499-1509. PubMed ID: 30905065
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of serum Mac-2-binding protein (M2BPGi) during regular follow-up of patients with biliary atresia.
Ueno T; Kodama T; Noguchi Y; Saka R; Takama Y; Tazuke Y; Bessho K; Okuyama H
Pediatr Surg Int; 2018 Oct; 34(10):1065-1071. PubMed ID: 30128700
[TBL] [Abstract][Full Text] [Related]
19. Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B.
Hsu YC; Jun T; Huang YT; Yeh ML; Lee CL; Ogawa S; Cho SH; Lin JT; Yu ML; Nguyen MH; Tanaka Y
Aliment Pharmacol Ther; 2018 Nov; 48(10):1128-1137. PubMed ID: 30306612
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of Mac-2-binding protein glycosylation isomer (M2BPGi) as a liver fibrosis marker in chronic hepatitis C patients with chronic kidney disease on hemodialysis.
Sulaiman AS; Hasan I; Hustrini NM; Lydia A; Hanifa RS; Gani RA
Clin Exp Nephrol; 2023 Jun; 27(6):557-564. PubMed ID: 36995542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
